Glück R
Schweiz, Serum- & Impfinstitut Bern.
Soz Praventivmed. 1997;42 Suppl 2:S100-6. doi: 10.1007/BF01365163.
Current influenza vaccines in use at present are predominantly inactivated virus vaccines. The vaccines currently in use are designated whole-virus vaccines, split virus vaccines or subunit vaccines. In Europe, two new types of influenza vaccines have reached the commercial introduction. One is produced in Italy and uses the new adjuvant MF59 to enhance the immune response. The other type is produced in Switzerland and uses phosphatidyl choline (lecithin) liposomes as surface antigen carriers.
目前正在使用的流感疫苗主要是灭活病毒疫苗。目前使用的疫苗分为全病毒疫苗、裂解病毒疫苗或亚单位疫苗。在欧洲，有两种新型流感疫苗已进入商业推广阶段。一种在意大利生产，使用新型佐剂MF59来增强免疫反应。另一种在瑞士生产，使用磷脂酰胆碱（卵磷脂）脂质体作为表面抗原载体。
